Investing in public graphene stocks - Page 3

Today we published a new edition of our Graphene Investment Guide, with all the latest information and financial updates from public graphene companies. This is still a challenging time for many graphene companies - and also for graphene investors, but we are seeing signs of increased activity and improved conditions in the graphene industry, which will hopefully contribute to public graphene companies.

It is a time of consolidation in the industry - and investors should be careful when looking at early stage graphene companies. Most graphene companies struggle to generate meaningful revenues, and we expect consolidation and liquidation to continue in the next few years.

The Graphene Investment Guide includes:

• An introduction to graphene
• An overview of graphene's most exciting applications
• An analysis of graphene's potential
• Market forecasts from leading analysts
• Detailed descriptions and financials of all public graphene companies
• Over 80 financial reports and company presentations (premium edition only)
• Graphene-Info's own investment thesis and action plan

Any technology-driven investor that wishes to stay current on the most promising new nanotechnology should look into this report. The report includes extensive data and information needed to launch a successful strategic graphene investment portfolio.

NanoXplore has reported its first quarter 2025 financial results. 

The Company revenue was CA$33.7 million (around US$24,220,000), up 16% from 1Q 2024. Net loss was CA$2.72 million (around US$1,950,000) - loss narrowed by 27% from 1Q 2024. The Company expects total revenues of between CA$140 million (over US$100,600,000) and CA$155 million (around US$111,400,000) for the year ending June 30, 2025.

Zentek has announced that its wholly-owned subsidiary Triera Biosciences has received a CAD$1.1 million (around USD$791,000) Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza (“HPAI”) A(H5N1).

Triera was awarded a these funds through Innovation, Science and Economic Development Canada's (“ISED”) Innovative Solutions Canada (“ISC”) program: Health Advanced And Emerging Medical Technologies. Triera’s multivalent aptamer technology was selected for its potential to be used as a rapid drug development platform.

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, has announced the closing of a $50 million Series B financing round. The round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, bringing the total amount raised since inception to $68 million.

In addition to the Series B round, INBRAIN also secured additional funding and support from Merck KGaA to advance the clinical development of its technology in Merck’s therapeutic areas of interest. This partnership will boost the translation of INBRAIN’s platform to human use, expanding its impact across both central and peripheral nervous system applications.

First Graphene has reported a promising quarter ending September 2024, with significant developments including a collaboration to enhance perovskite solar cells and a research initiative in the hydrogen sector. 

The company has generated approximately A$164,000 (almost USD$108,000) in income, capitalizing on graphene sales and development programs, and is looking to expand its market presence with new commercial opportunities in various sectors. These strategic moves aim to boost revenue and enhance shareholder value.

Haydale has announced that, further to its previous announcement on plans to raise funds, it has successfully completed the Fundraising which is now closed.

The Fundraising has successfully raised in aggregate £3 million (around USD$3.9 million). This comprises £2.5 million (about USD$3.25 million) raised through the Placing and Subscription of New Ordinary Shares, and the rest was raised through subscriptions for Convertible Loan Notes from Octopus Investments. 

Haydale has announced its intention to conduct a fundraising of up to £3.5 million (over USD$4.5 million) in aggregate, including a Placing of New Ordinary Shares, to raise in aggregate £2.17 million (over USD$2.8 million).

The Company proposes to raise a further £52,000 (around USD$67,300) from the Participating Directors, comprising the issue of New Ordinary Shares at the Issue Price. Certain Directors, namely Keith Broadbent, Theresa Wallis and Gareth Kaminski-Cook, intend to participate by way of the Subscription with David Banks intending to participate via the Placing.

2D Generation has announced that the Israel Innovation Authority has awarded the Company a grant of ILS 1.2 million (around USD$325,000), out of a project of ILS 2.4 million (around USD$650,000). 

2D Generation has stated that the grant validates its technological advancements, as well as the strength of its intellectual property and market potential. The Company will use the funding to fuel the ongoing development of its novel low-temperature graphene deposition technology, enabling new possibilities for graphene applications across various industries. 

U.S-based Lyten announced plans to invest more than $1 billion to build the world’s first Lithium-Sulfur battery gigafactory. The facility will be located near Reno, Nevada, and will have the capability to produce up to 10 GWh of batteries annually at full scale. Phase 1 of the facility is scheduled to come online in 2027.

Lyten’s proprietary processes permanently sequester carbon from methane in the form of 3D Graphene and utilize the supermaterial to develop decarbonizing applications. Lyten has received more than $425 million in investment from companies including Stellantis, FedEx, Honeywell, Walbridge, the European Investment Fund, and the Luxembourg Future Fund.

The European Investment Bank (EIB) is offering Italian materials manufacturer BeDimensional €20 million (almost USD$22 million) in venture debt financing to expand production of Few-Layer Graphene (FLG) and Few-Layer Hexagonal Boron Nitride (FLhBN or FLB).  

EIB Vice-President Gelsomina Vigliotti and BeDimensional Chief Executive Officer Vittorio Pellegrini announced the financing accord at the inauguration of the company's plant in Genoa. BeDimensional plans to build a second plant in Italy to scale-up production of FLG and FLB by 2027.